CVR 27987869Public limited company (A/S)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)HerlevFounded 20 Jul 2004
Employees
22
CVR, 2011
CVR registers no owner holding 5% or more.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexCVR registers no owner holding 5% or more.
Morten Asser Karsdaluntil 10 Sep 2012
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report a calibrated decision model reading the auditor's text, not registered by the company. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
20 Jul 2004 to 13 Nov 2026.
2011, annual: 22 employees, 22 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 12 | 12 | 14 | 18 | 19 | No count | No count | No count | No count | 22 |
| FTE | 1 | 7 | 9 | 10 | 13 | 18 | 23 | 24 | 24 | 25 | 22 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 2004 to 2009 and 2011; quarterly Q1 2010 to Q4 2010.
Latest 2011, published 18 Jul 2013. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
Not available in the CVR filing: the annual reports carry no machine-readable figures.
Annual report 2011
1 Jan 2011 to 31 Dec 2011, published 11 Jun 2012
Annual report 2010
1 Jan 2010 to 31 Dec 2010, published 6 Jun 2011
Annual report 2009
1 Jan 2009 to 31 Dec 2009, published 1 Jun 2010
Annual report 2008
1 Jan 2008 to 31 Dec 2008, published 9 Jun 2009
Annual report 2007
1 Jan 2007 to 31 Dec 2007, published 5 Jun 2008
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
Merger (fusion), as the ceasing company (ophørende selskab)
From CVR, read 13 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 13 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
10 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Selskabet opløst efter fusion med CVR-NR. 30799968 NORDIC BIOSCIENCE A/S, og selskabets binavn PHARMOS BIOSCIENCE A/S er slettet.
Erhvervsstyrelsen har modtaget fusionsplan
for den påtænkte fusion mellem
CVR-NR. 30799968 NORDIC BIOSCIENCE A/S (fortsættende).
CVR-NR. 27987869 NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S (ophørende), der tillige driver virksomhed under navnet PHARMOS BIOSCIENCE A/S.
CVR-NR. 30582497 NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S (ophørende).
Kapitalejerne i.
CVR-NR. 30799968 NORDIC BIOSCIENCE A/S.
CVR-NR. 27987869 NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S.
CVR-NR. 30582497 NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S, har i enighed besluttet,
at der ikke skal udarbejdes en erklæring om
kreditorernes stilling i forbindelse med fusionen.
Kreditorer, hvis fordringer er stiftet forud for
bekendtgørelsen om fusionen, og for hvilke der ikke er
stillet særskilt sikkerhed, kan anmelde deres fordringer
senest 4 uger efter at den endelige beslutning om fusion
er truffet.
Vedtægter ændret:
17.03.2011.
Selskabet tegnes af to medlemmer af bestyrelsen i forening, af et medlem af bestyrelsen og en direktør i forening eller af den samlede bestyrelse.
Vedtægter ændret:
11.02.2011.
Bestyrelse:
Udtrådt af bestyrelsen:
Per Qvist, den 11.02.2011.
Indtrådt i bestyrelsen:
Direktør Thomas Nielsen, den 11.02.2011.
Direktion:
Udtrådt af direktionen:
Per Qvist, den 11.02.2011.
Indtrådt i direktionen:
Morten Asser Karsdal, den 11.02.2011.
Vedtægter ændret:
24.06.2008.
Nyt navn:
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S.
Ny adresse:
Herlev Hovedgade 207, 2730 Herlev.
Ny kommune:
Herlev.
Nyt binavn: PHARMOS BIOSCIENCE A/S (NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S).
Vedtægter ændret:
30.01.2007.
Kapitalforhøjelse:
kr. 1.000,00 indbetalt kontant, kurs 2.500.000,00.
Kapitalen udgør herefter kr. 601.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Jesper Bay Esbensen, den 04.09.2006.
Indtrådt i bestyrelsen:
Direktør Bente Juel Christiansen, den 04.09.2006.
Vedtægter ændret:
30.03.2005.
Kapitalforhøjelse:
kr. 100.000,00 indbetalt ved konvertering af gæld, kurs 3.500,00.
Kapitalen udgør herefter kr. 600.000,00.
Vedtægter ændret:
13.12.2004.
Ny adresse:
Ballerup Byvej 222, 2750 Ballerup.
Ny kommune:
Ballerup.
Stiftelsesdato:
20.07.2004.
Seneste vedtægtsdato:
20.07.2004.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
CVR-NR. 21144347 NORDIC BIOSCIENCE A/S, Herlev Hovedgade 207, 2730 Herlev, den 20.07.2004.
Bestyrelse:
Direktør, Dr. med Claus Henrik Christiansen, den 20.07.2004, Økonomichef Jesper Bay Esbensen, den 20.07.2004, Per Qvist, den 20.07.2004.
Direktion:
Per Qvist (adm. dir), den 20.07.2004.
Selskabet tegnes af formanden for bestyrelsen i forening med en direktør, af to medlemmer af bestyrelsen i forening med en direktør, eller af den samlede bestyrelse.
Revision:
Revisionsfirmaet Ankjær-Jensen & Partnere, 2100 København Ø, den 20.07.2004.
Første regnskabsår:
20.07.2004 - 31.12.2004.
Regnskabsår:
01.01 - 31.12.
1 registered in CVR.
P-number 1010723139Herlev Hovedgade 207, 2730 Herlev